Karen Alt
- Biomedical Engineering top 5%
- Biomaterials top 1%
- Molecular Biology
- Materials Chemistry top 10%
- Radiology, Nuclear Medicine and Imaging top 5%
- Co-authors
- Christoph E. HagemeyerKarlheinz PeterFrank CarusoJoseph J. RichardsonJunling GuoYan YanHirotaka EjimaDominik von Elverfeldt
- Topics
- Monoclonal and Polyclonal Antibodies Research (16 papers)Peptidase Inhibition and Analysis (10 papers)Biochemical and Structural Characterization (8 papers)
- Partner nations
- AustraliaGermanyUnited States
In The Last Decade
Karen Alt
54 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Biomedical Engineering 854
- Biomaterials 777
- Molecular Biology 627
- Materials Chemistry 614
- Radiology, Nuclear Medicine and Imaging 387
Countries citing papers authored by Karen Alt
This map shows the geographic impact of Karen Alt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Alt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Alt more than expected).
Fields of papers citing papers by Karen Alt
This network shows the impact of papers produced by Karen Alt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Alt. The network helps show where Karen Alt may publish in the future.
Co-authorship network of co-authors of Karen Alt
This figure shows the co-authorship network connecting the top 25 collaborators of Karen Alt. A scholar is included among the top collaborators of Karen Alt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Alt. Karen Alt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 9 | |
| 3 | 7 | |
| 4 | 13 | |
| 5 | 22 | |
| 6 | 6 | |
| 7 | 46 | |
| 8 | 17 | |
| 9 | 36 | |
| 10 | 6 | |
| 11 | 4 | |
| 12 | 83 | |
| 13 | 44 | |
| 14 | 52 | |
| 15 | 43 | |
| 16 | 13 | |
| 17 | 73 | |
| 18 | 41 | |
| 19 | 73 | |
| 20 | 15 |
About Karen Alt
Karen Alt is a scholar working on Hematology, Immunology and Allergy and Radiology, Nuclear Medicine and Imaging, having authored 56 papers that have together received 2.7k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (16 papers), Peptidase Inhibition and Analysis (10 papers) and Biochemical and Structural Characterization (8 papers). The work is most often cited by research in Biomaterials (777 citations), Surfaces, Coatings and Films (338 citations) and Biomedical Engineering (854 citations). Karen Alt has collaborated with scholars based in Australia, Germany and United States. Frequent co-authors include Christoph E. Hagemeyer, Karlheinz Peter, Frank Caruso, Joseph J. Richardson, Junling Guo, Yan Yan, Hirotaka Ejima, Dominik von Elverfeldt, Mirko Meißner and Ping Yuan. Their work appears in journals such as Advanced Materials, Angewandte Chemie International Edition and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.